Denka Company Limited
4061.TBasic MaterialsTSEChemicals · Last scanned May 29, 2026
Scan Results
Daily timeframeDenka Company Limited manufactures and sells organic and inorganic, electronic material, pharmaceutical, and resin-related products in Japan, rest of Asia, and internationally. The company carries a $376.18B market cap, placing it firmly in the mega-cap category. It operates through Electronic & Innovative Products; Life Innovation; Elastomers & Infrastructure Solutions; Polymer Solutions; and Other Business segments.
Market Cap
$376.18B
Beta
0.26
P/E (TTM)
23.96
P/E (Fwd)
23.78
EPS (TTM)
$182.16
EPS (Fwd)
$183.52
ROE
3.5%
ROA
2.5%
Cash
$35.27B
Total Debt
$221.71B
Free CF
-$24.43B
52W Change
96.0%
Annual Financials
Cash vs Debt
On the balance sheet, 4061.T has $35.27B in cash with $221.71B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$24.43B, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of 3.5% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.5% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $384.85B (2022) to $400.25B (2025).
4061.T's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Denka Company Limited carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Denka Company Limited's trajectory.